TWO · 6748.TWO
ACRO Biomedical Co., Ltd.
NT$182.50-NT$11.50 (-5.93%)
ACRO Biomedical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 41.13% below the high.
Loading market information…
TAI · 1783.TW · TWD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
Maxigen Biotech Inc.’s quoted price sits in the lower half of its reported 52-week range, 27.33% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Maxigen Biotech Inc.’s forward annual dividend is NT$2.00 per share, paid annual. The forward yield is 5.7% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Maxigen Biotech Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Maxigen Biotech Inc. (MBI) is a company dedicated to the research, development, production, and global commercialization of advanced biomedical and skincare solutions. Its extensive biomedical portfolio includes various orthopedic products such as Formagraft, a bone graft substitute, and Formasetin, a bone void filler. For intra-articular applications in orthopedics, MBI markets injections under the names ArtiAid, ArtiAid Plus, and ArtiBest. The company's offerings also span both orthopedic and dental fields, featuring Foramic, a bone substitute granule; MaxiBone, a calcium phosphate ceramic; and GingivAid, a collagen dental graft. Specifically for dental use, MBI provides FormaAid, a collagen membrane, and the E-TECH DENTISTAR II sterilizer and disinfectant. Furthermore, HealiAid, a collagen wound dressing product, serves dental and general wound care purposes. MBI also manufactures ophthalmic viscoelastic devices, known as ViscAid, PreviscAid, and BiVisc, and produces Formaderm, a dermal filler injection utilized in plastic surgery. Beyond its medical devices, Maxigen Biotech Inc. offers a comprehensive line of skincare products. This array includes masks for the face, neck, body, and limbs, alongside make-up removers, cleansers, exfoliants, toners, essences, men's grooming items, sunscreens, and specialized body, hand, and foot care formulations. Maxigen Biotech Inc. was established in 1998 and operates from its main office in Taoyuan City, Taiwan.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:28 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$182.50-NT$11.50 (-5.93%)
ACRO Biomedical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 41.13% below the high.
NT$65.60+NT$5.30 (+8.79%)
Bionime Corporation’s quoted price sits in the upper half of its reported 52-week range, 10.01% below the high.
NT$43.50-NT$0.30 (-0.68%)
Orient EuroPharma Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 12.3% below the high.
NT$27.95-NT$0.45 (-1.58%)
BRIM Biotechnology, Inc.’s quoted price sits in the upper half of its reported 52-week range, 19.34% below the high.
NT$69.00-NT$0.50 (-0.72%)
ICARES Medicus, Inc.’s quoted price sits in the lower half of its reported 52-week range, 16.9% below the high.
NT$30.10-NT$0.40 (-1.31%)
Nang Kuang Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.04% below the high.
NT$18.75-NT$0.10 (-0.53%)
ShareHope Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 23.63% below the high.
NT$83.40-NT$2.40 (-2.8%)
Syngen Biotech Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.85% below the high.
